Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6842945> ?p ?o }
Showing triples 1 to 40 of
40
with 100 triples per page.
- Q6842945 subject Q7486806.
- Q6842945 subject Q8235519.
- Q6842945 subject Q8546978.
- Q6842945 subject Q8802906.
- Q6842945 abstract "Midostaurin (PKC412) is a multi-target protein kinase inhibitor being investigated for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It is a semi-synthetic derivative of staurosporine, an alkaloid from the bacterium Streptomyces staurosporeus, and is active in patients with mutations of CD135 (FMS-like tyrosine kinase 3 receptor, FLT3).After successful Phase II clinical trials, a Phase III trial for AML has started in 2008. It is testing midostaurin in combination with daunorubicin and cytarabine. In another trial, the substance has proven ineffective in metastatic melanoma.".
- Q6842945 atcPrefix "None".
- Q6842945 casNumber "120685-11-2".
- Q6842945 fdaUniiCode "ID912S5VON".
- Q6842945 iupacName "(9S,10R,11R,13R)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiamzonine-1-one".
- Q6842945 pubchem "9829523".
- Q6842945 thumbnail Midostaurin_skeletal.svg?width=300.
- Q6842945 wikiPageWikiLink Q1144013.
- Q6842945 wikiPageWikiLink Q14912399.
- Q6842945 wikiPageWikiLink Q180614.
- Q6842945 wikiPageWikiLink Q180983.
- Q6842945 wikiPageWikiLink Q181876.
- Q6842945 wikiPageWikiLink Q264118.
- Q6842945 wikiPageWikiLink Q30612.
- Q6842945 wikiPageWikiLink Q411659.
- Q6842945 wikiPageWikiLink Q5957181.
- Q6842945 wikiPageWikiLink Q70702.
- Q6842945 wikiPageWikiLink Q7251487.
- Q6842945 wikiPageWikiLink Q7486806.
- Q6842945 wikiPageWikiLink Q8235519.
- Q6842945 wikiPageWikiLink Q8546978.
- Q6842945 wikiPageWikiLink Q8802906.
- Q6842945 wikiPageWikiLink Q954625.
- Q6842945 atcPrefix "None".
- Q6842945 casNumber "120685".
- Q6842945 iupacName "120.0".
- Q6842945 pubchem "9829523".
- Q6842945 unii "ID912S5VON".
- Q6842945 type ChemicalSubstance.
- Q6842945 type Drug.
- Q6842945 type ChemicalObject.
- Q6842945 type Thing.
- Q6842945 type Q8386.
- Q6842945 comment "Midostaurin (PKC412) is a multi-target protein kinase inhibitor being investigated for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It is a semi-synthetic derivative of staurosporine, an alkaloid from the bacterium Streptomyces staurosporeus, and is active in patients with mutations of CD135 (FMS-like tyrosine kinase 3 receptor, FLT3).After successful Phase II clinical trials, a Phase III trial for AML has started in 2008.".
- Q6842945 label "Midostaurin".
- Q6842945 depiction Midostaurin_skeletal.svg.